Investors Buy Shares of UnitedHealth Group Incorporated (UNH) on Weakness

Traders purchased shares of UnitedHealth Group Incorporated (NYSE:UNH) on weakness during trading on Tuesday. $115.67 million flowed into the stock on the tick-up and $90.63 million flowed out of the stock on the tick-down, for a money net flow of $25.04 million into the stock. Of all equities tracked, UnitedHealth Group had the 19th highest net in-flow for the day. UnitedHealth Group traded down ($1.62) for the day and closed at $194.68

UNH has been the subject of several research analyst reports. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday. Morgan Stanley boosted their price target on shares of UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, June 28th. ValuEngine lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Sanford C. Bernstein reissued an “outperform” rating and issued a $190.00 price target on shares of UnitedHealth Group in a report on Monday, July 10th. Finally, Deutsche Bank AG boosted their price target on shares of UnitedHealth Group from $187.00 to $197.00 and gave the company a “buy” rating in a report on Thursday, July 13th. Three investment analysts have rated the stock with a hold rating and twenty-three have assigned a buy rating to the stock. UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $203.59.

The company has a 50-day moving average price of $196.59 and a 200-day moving average price of $184.23. The firm has a market capitalization of $188.23 billion, a P/E ratio of 23.39 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. The firm had revenue of $50.05 billion for the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The company’s quarterly revenue was up 7.7% on a year-over-year basis. During the same period in the previous year, the company earned $1.96 earnings per share. Analysts anticipate that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th were given a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.54%. The ex-dividend date was Thursday, September 7th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 35.13%.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the sale, the director now owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the completion of the sale, the director now directly owns 60,834 shares in the company, valued at approximately $12,135,774.66. The disclosure for this sale can be found here. In the last three months, insiders sold 76,174 shares of company stock worth $14,981,909. Insiders own 0.89% of the company’s stock.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Honeywell International Inc. bought a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $35,262,000. Schwab Charles Investment Management Inc. raised its position in shares of UnitedHealth Group by 5.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock valued at $678,077,000 after purchasing an additional 183,401 shares during the period. Suntrust Banks Inc. raised its position in shares of UnitedHealth Group by 8.5% in the first quarter. Suntrust Banks Inc. now owns 260,811 shares of the healthcare conglomerate’s stock valued at $42,774,000 after purchasing an additional 20,541 shares during the period. Factory Mutual Insurance Co. raised its position in shares of UnitedHealth Group by 20.9% in the second quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock valued at $77,245,000 after purchasing an additional 72,000 shares during the period. Finally, Shell Asset Management Co. raised its position in shares of UnitedHealth G

UNH has been the subject of several research analyst reports. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday. Morgan Stanley boosted their price target on shares of UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, June 28th. ValuEngine lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Sanford C. Bernstein reissued an “outperform” rating and issued a $190.00 price target on shares of UnitedHealth Group in a report on Monday, July 10th. Finally, Deutsche Bank AG boosted their price target on shares of UnitedHealth Group from $187.00 to $197.00 and gave the company a “buy” rating in a report on Thursday, July 13th. Three investment analysts have rated the stock with a hold rating and twenty-three have assigned a buy rating to the stock. UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $203.59.

The company has a 50-day moving average price of $196.59 and a 200-day moving average price of $184.23. The firm has a market capitalization of $188.23 billion, a P/E ratio of 23.39 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. The firm had revenue of $50.05 billion for the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The company’s quarterly revenue was up 7.7% on a year-over-year basis. During the same period in the previous year, the company earned $1.96 earnings per share. Analysts anticipate that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th were given a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.54%. The ex-dividend date was Thursday, September 7th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 35.13%.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the sale, the director now owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the completion of the sale, the director now directly owns 60,834 shares in the company, valued at approximately $12,135,774.66. The disclosure for this sale can be found here. In the last three months, insiders sold 76,174 shares of company stock worth $14,981,909. Insiders own 0.89% of the company’s stock.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Honeywell International Inc. bought a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $35,262,000. Schwab Charles Investment Management Inc. raised its position in shares of UnitedHealth Group by 5.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock valued at $678,077,000 after purchasing an additional 183,401 shares during the period. Suntrust Banks Inc. raised its position in shares of UnitedHealth Group by 8.5% in the first quarter. Suntrust Banks Inc. now owns 260,811 shares of the healthcare conglomerate’s stock valued at $42,774,000 after purchasing an additional 20,541 shares during the period. Factory Mutual Insurance Co. raised its position in shares of UnitedHealth Group by 20.9% in the second quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock valued at $77,245,000 after purchasing an additional 72,000 shares during the period. Finally, Shell Asset Management Co. raised its position in shares of UnitedHealth Group by 0.8% in the second quarter. Shell Asset Management Co. now owns 157,241 shares of the healthcare conglomerate’s stock valued at $29,156,000 after purchasing an additional 1,254 shares during the period. 86.19% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This article was originally reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://ledgergazette.com/2017/10/10/investors-buy-shares-of-unitedhealth-group-incorporated-unh-on-weakness-3.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply